Independent fund research. Built on SEC filings.

How we research funds

ETF · Health Care Sector · ProShares

RXL Expense Ratio & Fees

Ticker RXL · · Holdings as of May 31, 2026

Expense ratio
0.95%$95/yr per $10k
5-yr return
+7.2%annualized
1-yr return
+19.7%as of Dec 2025
Net assets
$72.1Mall share classes
Holdings
70

Bottom line

What is RXL's expense ratio?

RXL's expense ratio is 0.95%, or about $95 a year on every $10,000 invested. That is cheaper than 50% of health care sector funds we track (median 0.96%).

Updated Sep 25, 2026

RXL fee table

Net expense ratio0.95%
Gross expense ratio1.08%
Management fee0.75%
Other expenses0.33%
Fee waiver / reimbursement-0.13%
Max front-end sales loadNone (ETF)

Source: Fund prospectus fee table, filed Sep 25, 2026

What RXL costs in dollars

The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:

1 year3 years5 years10 years
RXL$97$331$583$1,305

Source: Fund prospectus expense example

The long-run cost of fees

On $100,000 growing at 6% a year for 20 years, a 0.95% expense ratio costs roughly $52,800 in lost growth, versus about $53,400 for the median health care sector fund (0.96%).

Cheaper alternatives to RXL

These funds have a similar portfolio (by top-holdings overlap) and a lower expense ratio. Savings are per $10,000 invested.

FundExpense ratioSaves per yearSaves over 20 yrs*Overlap
XLV SPDR (State Street)0.08%$87$4,80478%
FHLC Fidelity0.084%$87$4,78078%
VHT Vanguard0.09%$86$4,74476%
IXJ iShares0.38%$57$3,06273%
JDOC J.P. Morgan0.65%$30$1,57251%

*Difference in ending value of $10,000 after 20 years at a 6% gross annual return, net of each fund's expense ratio.